facts about glutathione and parkinson's disease S-transferase: A keystone in pathogenesis therapy Frontiers | Targeting Mitochondrial Impairment

Mice were housed individually in automated food-monitoring cages and acclimated for two weeks before testing

Patients with neurological symptoms require more intensive treatment with alternate-day injections until improvement plateaus, and may need more frequent maintenance dosing

It turns out GHK and Cu love each other, and if they meet, they form a complex that is called copper-tripeptide

Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinsons disease with motor fluctuations: a multicenter study

This damage often leads to "stiff" blood vessels that cannot relax properly, contributing to high blood pressure (hypertension)